FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/099156 [Registered on: 15/12/2025] Trial Registered Prospectively
Last Modified On: 15/12/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Behavioral 
Study Design  Other 
Public Title of Study   A study in doctors and patients to find out whether giving emotional-intelligence training to doctors can improve how they communicate with patients, and whether it helps patients follow treatment better and feel more satisfied with their care. 
Scientific Title of Study   A single centre, Prospective, Open-label, nonrandomized, interventional study to Evaluate the Impact of Emotional Intelligence Training and Management on Doctor–Patient Communication, Adherence, and Satisfaction in a Tertiary Care Hospital of District Thane, Maharashtra. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ila Ghosh 
Designation  Manager Medical Administration 
Affiliation  Bhaktivedanta Hospital and Research Institute 
Address  Bhaktivedanta Hospital and Research Institute, Bhaktivedanta Swami Marg, Sector 6, Sector 2, Srishti Complex, Mira Road East, Thane, Maharashtra, India 401107.

Thane
MAHARASHTRA
401107
India 
Phone  9321046443  
Fax    
Email  drila.g@bhaktivedantahospital.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ila Ghosh 
Designation  Manager Medical Administration 
Affiliation  Bhaktivedanta Hospital and Research Institute 
Address  Bhaktivedanta Hospital and Research Institute, Bhaktivedanta Swami Marg, Sector 6, Sector 2, Srishti Complex, Mira Road East, Thane, Maharashtra, India 401107.

Thane
MAHARASHTRA
401107
India 
Phone  9321046443  
Fax    
Email  drila.g@bhaktivedantahospital.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ila Ghosh 
Designation  Manager Medical Administration 
Affiliation  Bhaktivedanta Hospital and Research Institute 
Address  Bhaktivedanta Hospital and Research Institute, Bhaktivedanta Swami Marg, Sector 6, Sector 2, Srishti Complex, Mira Road East, Thane, Maharashtra, India 401107.

Thane
MAHARASHTRA
401107
India 
Phone  9321046443  
Fax    
Email  drila.g@bhaktivedantahospital.com  
 
Source of Monetary or Material Support  
Bhaktivedanta Hospital and Research Institute, Bhaktivedanta Swami Marg, Sector 6, Sector 2, Srishti Complex, Mira Road East, Thane, Maharashtra, India 401107. 
 
Primary Sponsor  
Name  Bhaktivedanta Hospital and Research Institute 
Address  Bhaktivedanta Swami Marg, Sector 6, Sector 2, Srishti Complex, Mira Road East, Thane, Maharashtra, India 401107. 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ila Ghosh  Bhaktivedanta Hospital and Research Institute.  Bhaktivedanta Hospital and Research Institute, Bhaktivedanta Swami Marg, Sector 6, Sector 2, Srishti Complex, Mira Road East, Thane, Maharashtra, India 401107.
Thane
MAHARASHTRA 
9321046443

drila.g@bhaktivedantahospital.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Bhaktivedanta Hospital Ethics Committee for Biomedical and Health Research   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 8||Other Procedures,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Standard of care  Standard of care 
Intervention  Structured Emotional Intelligence (EI) training program.  The intervention involves a structured Emotional Intelligence (EI) training program for doctors, designed to enhance their communication skills and interpersonal effectiveness in clinical settings. The training will focus on key EI competencies such as self-awareness, empathy, emotional regulation, interpersonal sensitivity, and conflict resolution. It will be delivered through interactive and experiential methods, including case studies, role plays, reflective exercises, and group discussions, facilitated by experts in emotional intelligence and healthcare communication.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  85.00 Year(s)
Gender  Both 
Details  For Doctors:
1.Actively involved in direct patient care across various departments.
2.Minimum of more than 3 year of clinical experience post-qualification.
3.Willingness to participate in all phases of the study, including training and follow-up assessments.
4.Ability to understand and complete self-report questionnaires in the language of administration.
5.Provided informed consent.

For Patients:
1.Under the care of participating doctors during the study period.
2.Aged 18 years or older.
3.Capable of understanding and responding to the treatment adherence and satisfaction questionnaires.
4.Provided informed consent.
5.Available for follow-up assessments at designated time points
 
 
ExclusionCriteria 
Details  For Doctors:
1.Administrative or non-clinical roles with no direct patient interaction.
2.Prior formal training in emotional intelligence or communication skills within the last 12 months.
3.Unwilling or unable to attend the full training and reinforcement sessions.
4.Currently involved in another interventional study that may influence communication behaviour.

For Patients:
1.Cognitive impairments or psychiatric conditions that hinder reliable self-reporting.
2.Language barriers that prevent understanding of the questionnaire (unless translated versions are available).
3.Terminal illness or critical condition requiring intensive care.
4.Participation in another study that may affect treatment adherence or satisfaction.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.To determine the effectiveness of emotional intelligence training in improving doctors’ communication skills and patient satisfaction.
 
1 month and 3 months post training.
 
 
Secondary Outcome  
Outcome  TimePoints 
To assess doctors’ emotional intelligence levels, examine their correlation with patient adherence and satisfaction, and identify challenges affecting the application of emotional intelligence in doctor–patient interactions.  1 month and 3 months post training.
 
 
Target Sample Size   Total Sample Size="131"
Sample Size from India="131" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   24/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  24/12/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This single-centre, prospective, open-label, non-randomized interventional study aims to evaluate the impact of Emotional Intelligence (EI) training on doctor–patient communication, treatment adherence, and patient satisfaction at a tertiary care hospital in Thane, Maharashtra. The study will enroll 84 doctors involved in direct patient care and 131 adult patients under their care. Doctors will undergo a structured EI training program focused on self-awareness, empathy, emotional regulation, interpersonal sensitivity, and communication skills, delivered through interactive sessions including case studies, role plays, and group discussions. Doctors’ EI levels (TEIQue-SF), patient satisfaction (PSQ-18), and treatment adherence will be assessed at baseline, 1 month, and 3 months post-training. Eligible participants include doctors with at least three years of clinical experience and patients aged 18 years or older capable of completing questionnaires, while participants with cognitive impairments, prior EI training, or conflicting study involvement are excluded. The study duration is six months. The primary endpoint is the change in doctors’ EI scores, and secondary endpoints include changes in patient treatment adherence and satisfaction. All adverse events and serious adverse events will be reported to the Ethics Committee, and participant confidentiality will be maintained. 
Close